Sample Size Planning – Experience from Reviewing Psychiatric Clinical Trials
*Peiling Yang, US FDA 

Keywords: Sample Size

In this talk, I will summarize the sample size planning from completed trials and explore the differences in this aspect between positive and negative trials using information collected from the FDA archived database. I will also provide an overview of sample size planning that was recently proposed in ongoing trials and discuss the pros and cons.